Literature DB >> 11588819

Clinicostatistical study of ameloblastoma treatment.

K Hatada1, H Noma, A Katakura, M Yama, M Takano, Y Ide, T Takaki, Y Yajima, T Shibahara, T Kakizawa, M Tonogi, G Yamane.   

Abstract

The purpose of this study was to investigate the treatment of 190 cases of ameloblastoma in our department from 1966 to 1994. The statistical results with regard to age, sex and region agreed with those of other investigators. Thirty-five of 43 (81.4%) cases underwent enucleation in 1960s, but the sixteen of 27 (59.3%) cases underwent partial resection of mandible in 1990s. The defect of mandible was reconstructed with iliac bone grafting since 1968, grafts with a mixture of iliac blocked bone and PCBM (particulate cancellous bone and marrow) have been used since 1975. Grafting of the inferior alveolar nerve with the great auricular nerve to the defect has been performed in our department since 1977. Recently, technique involving pull-through of the inferior alveolar nerve bundle has been used in our department. When the reconstruction method for the mandible and nerve has been established, it becomes possible to operate radically and positively. Recurrence occurred in 17 cases after the primary enucleation. It is thought that the primary treatment of ameloblastoma must be as radical as possible. It appears to be necessary to observe progress and perform follow-up in cases of ameloblastoma for more than ten years, because there was one recurrence at 9 years and 4 months after the first operation. In fact, three quarters of our cases were lost to follow-up. Such losses can problems in confirming recurrence and responding rapidly.

Entities:  

Mesh:

Year:  2001        PMID: 11588819     DOI: 10.2209/tdcpublication.42.87

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  5 in total

1.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

2.  Off-label use of rhBMP-2 as bone regeneration strategies in mandibular ameloblastoma unicystic.

Authors:  Henrique Celestino Lima E Silva; Adonai Peixoto Cheim; Roberto Moreno; Sérgio Luis de Miranda
Journal:  Einstein (Sao Paulo)       Date:  2017 Jan-Mar

3.  The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study.

Authors:  M Ruslin; F-N Hendra; A Vojdani; D Hardjosantoso; M Gazali; A Tajrin; J Wolff; T Forouzanfar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-01-01

Review 4.  Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor.

Authors:  Suhani Ghai
Journal:  Cureus       Date:  2022-08-06

5.  [Comparison of clinical immunohistochemical findings in keratocystic odontogenic tumours and ameloblastomas considering their risk of recurrence].

Authors:  Oliver Driemel; Johanna Rieder; Christian Morsczeck; Stephan Schwarz; Samer George Hakim; Urs Müller-Richter; Torsten Eugen Reichert; Hartwig Kosmehl
Journal:  Mund Kiefer Gesichtschir       Date:  2007-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.